Researchers with type 2 diabetes following a retatrutide dose schedule need to monitor blood glucose closely during each escalation step, as the improved insulin sensitivity can cause hypoglycemia if diabetes medications are not adjusted accordingly
doi: 10.1016/j.bbamcr.2012.01.005 47 CoppsKWhiteMJD
Online influencers and "biohacking" communities frequently promote them as tools to optimize performance, accelerate healing or improve longevity
7 : 147154 Terwel D, Prickaerts J, Meng F, Jolles J
Nausea, vomiting, flatulence (gas), and indigestion also occur in many patients
Verdict at a Glance Orforglipron represents a potential paradigm shift as the first oral non-peptide GLP-1 agonist without fasting restrictions, and it demonstrated superiority over oral semaglutide in the head-to-head ACHIEVE-3 trial for both HbA1c and weight loss